Skip to main content
Fig. 1 | Cancer Imaging

Fig. 1

From: Applying arterial enhancement fraction (AEF) texture features to predict the tumor response in hepatocellular carcinoma (HCC) treated with Transarterial chemoembolization (TACE)

Fig. 1

The workflow of the present study. HCC: Hepatocellular carcinoma; HMC: Hepatic metastatic cancer; ICC: Intrahepatic cholangiocarcinoma; TACE: Transarterial chemoembolization; AVS: Arterial-portal vein shunt; AEF: Arterial enhancement fraction; ROI: Region of interest. Numbers in gray represented the cases that passed every step through the inclusion process. Imaging processing was conducted by a CT kinetics program. Compared with CT images, AEF maps presented a better contrast of HCC (Warmer color) to the background tissue (A, B [19], C). A non-perfusion area (Red arrows) indicated a good lipiodol accumulation from previous TACE intervention

Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us